Market Cap 148.62M
Revenue (ttm) 60,000.00
Net Income (ttm) -55.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -92,466.67%
Debt to Equity Ratio 0.00
Volume 428,900
Avg Vol 489,400
Day's Range N/A - N/A
Shares Out 62.97M
Stochastic %K 21%
Beta -0.23
Analysts Strong Sell
Price Target $7.25

Company Profile

Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 877 245 2787
Address:
3580 Carmel Mountain Road, Suite 200, San Diego, United States
mikeywo
mikeywo Aug. 24 at 11:45 PM
$CNTB can we get 8 more watchers ? Let’s break 900. 8 days til Sept. hopefully we get two blowout readings with data so good it’s hard to believe.
0 · Reply
Idfkytm
Idfkytm Aug. 23 at 4:15 PM
$CNTB 👀
0 · Reply
bhos
bhos Aug. 21 at 9:34 PM
$CNTB Im hopeful to see 10% over next few weeks.
1 · Reply
dcrown
dcrown Aug. 21 at 5:03 PM
$CNTB @mikeywo imonhe gets the idea https://pharmaboardroom.com/interviews/barry-quart-ceo-connect-biopharma/
3 · Reply
mikeywo
mikeywo Aug. 21 at 4:24 PM
$CNTB @dcrown yep the market knows all that and here we sit at 2.20$ it’s frustrating that Barry seems to be spending the summer in the South Pacific. If this doesn’t move after data and he doesn’t get out of the office and go on a road show hitting every bio conference he can this could have the same fate as other promising bios and sink to under 1$ and have to reverse split due to the threat of Delisting. It’s happened to many companies With just as much Promise as Rademikibart had. IMO This CEO isn’t getting it done.
0 · Reply
dcrown
dcrown Aug. 21 at 2:51 PM
$CNTB very interesting Over 1.0 million asthma patients and 1.3 million COPD patients end up in the ER every year due to acute attacks.Zero Direct Biologic Competition: Existing respiratory blockbusters are approved strictly for chronic maintenance global peak sales across both its chronic and acute indications to exceed $5 billion Phase 1 pharmacology data confirmed that a single 2-minute intravenous (IV) push of rademikibart gave patients rapid airway improvement (≥200 mL FEV1) in as little as 15 minutes, holding steady for a month. This quick-acting bronchodilation effect is why it can target emergency rooms where other biologics cannot. the independent Data Monitoring Committee (DMC) conducted a pre-specified interim analysis on the Seabreeze STAT studies. They allowed enrollment to continue exactly as planned with no safety concerns, no serious adverse events, and zero dropouts due to side effects
1 · Reply
click_420
click_420 Aug. 21 at 1:36 PM
$CNTB if it keeps going I'll be averaging down lol
0 · Reply
great_investment_thesis
great_investment_thesis Aug. 21 at 6:23 AM
$CNTB New here, bought 5K shares in the last few days. The asymmetric potential is hard to comprehend, and I’m not sure how this company still flies under the radar. The downside seems limited by what we already have in China and the success of Phase 2, while the upside can only really be measured after the data readouts in September. I can imagine an easy 100% from here, maybe even 200% with a partnership for Phase 3. Nevertheless, I have two red flags: - The C-level seems against selling the company right after Phase 2 and wants to partner the assets instead. If that’s the case, this becomes a much longer game. - At the end of the day, the company is Chinese, and my experience with Chinese companies is only negative. In too many cases, you end up dealing with absolute scammers. I simply don’t trust anything coming out of China, which is why I’m keeping my exposure limited.
3 · Reply
click_420
click_420 Aug. 20 at 12:55 AM
$CNTB thinking of averaging up and adding to my position. Still under the radar
0 · Reply
TheGodsMustBeCrazy
TheGodsMustBeCrazy Aug. 19 at 2:38 PM
$CNTB has 884 watchers right now. Just watch what happens to that number in 2-3 weeks.
1 · Reply
Latest News on CNTB
Connect Biopharma Holdings Earnings release: Q2 2026

Aug 12, 2026, 4:00 PM EDT - 12 days ago

Connect Biopharma Holdings Earnings release: Q2 2026


Connect Biopharma Holdings Quarterly report: Q2 2026

Aug 12, 2026, 4:00 PM EDT - 12 days ago

Connect Biopharma Holdings Quarterly report: Q2 2026


Connect Biopharma Holdings Slides: Corporate presentation

Jul 14, 2026, 9:00 AM EDT - 5 weeks ago

Connect Biopharma Holdings Slides: Corporate presentation


Connect Biopharma initiated with an Outperform at Oppenheimer

2026-07-09T12:00:36.000Z - 6 weeks ago

Connect Biopharma initiated with an Outperform at Oppenheimer


Connect Biopharma initiated with an Overweight at Piper Sandler

2026-06-26T10:00:38.000Z - 2 months ago

Connect Biopharma initiated with an Overweight at Piper Sandler


Connect Biopharma initiated with a Buy at Canaccord

2026-05-26T09:25:05.000Z - 3 months ago

Connect Biopharma initiated with a Buy at Canaccord


Connect Biopharma Holdings Slides: Corporate presentation

May 14, 2026, 7:00 AM EDT - 3 months ago

Connect Biopharma Holdings Slides: Corporate presentation


Connect Biopharma Holdings Earnings release: Q1 2026

May 12, 2026, 9:00 AM EDT - 3 months ago

Connect Biopharma Holdings Earnings release: Q1 2026


Connect Biopharma Holdings Quarterly report: Q1 2026

May 12, 2026, 9:00 AM EDT - 3 months ago

Connect Biopharma Holdings Quarterly report: Q1 2026


Connect Biopharma announces enrollment in Seabreeze STAT study

2026-04-23T13:29:20.000Z - 4 months ago

Connect Biopharma announces enrollment in Seabreeze STAT study


Connect Biopharma director buys $4.0M in common stock

2026-04-01T21:15:48.000Z - 5 months ago

Connect Biopharma director buys $4.0M in common stock


Connect Biopharma Holdings Annual report: Q4 2025

Mar 31, 2026, 4:00 PM EDT - 5 months ago

Connect Biopharma Holdings Annual report: Q4 2025


Connect Biopharma Holdings Earnings release: Q4 2025

Mar 31, 2026, 4:00 PM EDT - 5 months ago

Connect Biopharma Holdings Earnings release: Q4 2025


Connect Biopharma Holdings Transcript: Study result

Mar 30, 2026, 8:00 AM EDT - 5 months ago

Connect Biopharma Holdings Transcript: Study result


Connect Biopharma Holdings Press release: Study result

Mar 30, 2026, 8:00 AM EDT - 5 months ago

Connect Biopharma Holdings Press release: Study result


Connect Biopharma Holdings Slides: Study result

Mar 30, 2026, 8:00 AM EDT - 5 months ago

Connect Biopharma Holdings Slides: Study result


Connect Biopharma announces results from rademikibart study

2026-03-30T11:26:39.000Z - 5 months ago

Connect Biopharma announces results from rademikibart study


Connect Biopharma Holdings Slides: FY 2026

Mar 10, 2026, 8:00 AM EDT - 5 months ago

Connect Biopharma Holdings Slides: FY 2026


Connect Biopharma Holdings Slides: Corporate presentation

Jan 12, 2026, 7:00 AM EST - 8 months ago

Connect Biopharma Holdings Slides: Corporate presentation


Connect Biopharma initiated with a Buy at Lake Street

2025-12-01T13:45:55.000Z - 9 months ago

Connect Biopharma initiated with a Buy at Lake Street


Connect Biopharma Holdings Quarterly report: Q3 2025

Nov 12, 2025, 9:00 AM EST - 10 months ago

Connect Biopharma Holdings Quarterly report: Q3 2025


Connect Biopharma Holdings Earnings release: Q3 2025

Nov 12, 2025, 9:00 AM EST - 10 months ago

Connect Biopharma Holdings Earnings release: Q3 2025


Connect Biopharma Holdings Transcript: Status Update

Nov 3, 2025, 4:15 PM EST - 10 months ago

Connect Biopharma Holdings Transcript: Status Update


Connect Biopharma initiated with a Buy at BTIG

2025-10-31T10:10:32.000Z - 10 months ago

Connect Biopharma initiated with a Buy at BTIG


Connect Biopharma presents data on rademikibart at ERS Congress

2025-09-29T13:21:17.000Z - 11 months ago

Connect Biopharma presents data on rademikibart at ERS Congress


Connect Biopharma Holdings Quarterly report: H1 2025

Aug 13, 2025, 9:00 AM EDT - 1 year ago

Connect Biopharma Holdings Quarterly report: H1 2025


Connect Biopharma Holdings Earnings release: H1 2025

Aug 13, 2025, 9:00 AM EDT - 1 year ago

Connect Biopharma Holdings Earnings release: H1 2025


Connect Biopharma Holdings Slides: Corporate Presentation

Jun 3, 2025, 7:00 AM EDT - 1 year ago

Connect Biopharma Holdings Slides: Corporate Presentation


Connect Biopharma Holdings Quarterly report: Q1 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

Connect Biopharma Holdings Quarterly report: Q1 2025


Connect Biopharma Holdings Earnings release: Q1 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

Connect Biopharma Holdings Earnings release: Q1 2025


Connect Biopharma Holdings Earnings release: H2 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

Connect Biopharma Holdings Earnings release: H2 2024


Connect Biopharma Holdings Annual report: H2 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

Connect Biopharma Holdings Annual report: H2 2024


Attovia Therapeutics Appoints Chief Financial Officer

Oct 15, 2024, 7:30 AM EDT - 2 years ago

Attovia Therapeutics Appoints Chief Financial Officer


CNTB Stock Dips Amid Biotech Sector Volatility

Oct 9, 2024, 3:55 PM EDT - 2 years ago

CNTB Stock Dips Amid Biotech Sector Volatility


CNTB Stock Surges Over 5% Amid Strong Financial Performance

Oct 2, 2024, 4:14 PM EDT - 2 years ago

CNTB Stock Surges Over 5% Amid Strong Financial Performance


Connect Biopharma Holdings Quarterly report: H1 2024

Sep 5, 2024, 4:00 PM EDT - 2 years ago

Connect Biopharma Holdings Quarterly report: H1 2024


Connect Biopharma Holdings Slides: Corporate Presentation

Aug 6, 2024, 2:00 AM EDT - 2 years ago

Connect Biopharma Holdings Slides: Corporate Presentation


Connect Biopharma Holdings Annual report: H2 2023

Apr 16, 2024, 4:00 PM EDT - 2 years ago

Connect Biopharma Holdings Annual report: H2 2023


Connect Biopharma Holdings Quarterly report: H2 2023

Apr 16, 2024, 4:00 PM EDT - 2 years ago

Connect Biopharma Holdings Quarterly report: H2 2023


mikeywo
mikeywo Aug. 24 at 11:45 PM
$CNTB can we get 8 more watchers ? Let’s break 900. 8 days til Sept. hopefully we get two blowout readings with data so good it’s hard to believe.
0 · Reply
Idfkytm
Idfkytm Aug. 23 at 4:15 PM
$CNTB 👀
0 · Reply
bhos
bhos Aug. 21 at 9:34 PM
$CNTB Im hopeful to see 10% over next few weeks.
1 · Reply
dcrown
dcrown Aug. 21 at 5:03 PM
$CNTB @mikeywo imonhe gets the idea https://pharmaboardroom.com/interviews/barry-quart-ceo-connect-biopharma/
3 · Reply
mikeywo
mikeywo Aug. 21 at 4:24 PM
$CNTB @dcrown yep the market knows all that and here we sit at 2.20$ it’s frustrating that Barry seems to be spending the summer in the South Pacific. If this doesn’t move after data and he doesn’t get out of the office and go on a road show hitting every bio conference he can this could have the same fate as other promising bios and sink to under 1$ and have to reverse split due to the threat of Delisting. It’s happened to many companies With just as much Promise as Rademikibart had. IMO This CEO isn’t getting it done.
0 · Reply
dcrown
dcrown Aug. 21 at 2:51 PM
$CNTB very interesting Over 1.0 million asthma patients and 1.3 million COPD patients end up in the ER every year due to acute attacks.Zero Direct Biologic Competition: Existing respiratory blockbusters are approved strictly for chronic maintenance global peak sales across both its chronic and acute indications to exceed $5 billion Phase 1 pharmacology data confirmed that a single 2-minute intravenous (IV) push of rademikibart gave patients rapid airway improvement (≥200 mL FEV1) in as little as 15 minutes, holding steady for a month. This quick-acting bronchodilation effect is why it can target emergency rooms where other biologics cannot. the independent Data Monitoring Committee (DMC) conducted a pre-specified interim analysis on the Seabreeze STAT studies. They allowed enrollment to continue exactly as planned with no safety concerns, no serious adverse events, and zero dropouts due to side effects
1 · Reply
click_420
click_420 Aug. 21 at 1:36 PM
$CNTB if it keeps going I'll be averaging down lol
0 · Reply
great_investment_thesis
great_investment_thesis Aug. 21 at 6:23 AM
$CNTB New here, bought 5K shares in the last few days. The asymmetric potential is hard to comprehend, and I’m not sure how this company still flies under the radar. The downside seems limited by what we already have in China and the success of Phase 2, while the upside can only really be measured after the data readouts in September. I can imagine an easy 100% from here, maybe even 200% with a partnership for Phase 3. Nevertheless, I have two red flags: - The C-level seems against selling the company right after Phase 2 and wants to partner the assets instead. If that’s the case, this becomes a much longer game. - At the end of the day, the company is Chinese, and my experience with Chinese companies is only negative. In too many cases, you end up dealing with absolute scammers. I simply don’t trust anything coming out of China, which is why I’m keeping my exposure limited.
3 · Reply
click_420
click_420 Aug. 20 at 12:55 AM
$CNTB thinking of averaging up and adding to my position. Still under the radar
0 · Reply
TheGodsMustBeCrazy
TheGodsMustBeCrazy Aug. 19 at 2:38 PM
$CNTB has 884 watchers right now. Just watch what happens to that number in 2-3 weeks.
1 · Reply
TheGodsMustBeCrazy
TheGodsMustBeCrazy Aug. 19 at 2:29 PM
$CNTB price targets for cntb are about to go through the roof. Fewer than a thousand people follow this account on this app rn. That is miniscule compared to other small cap biotech. Just wait until people discover this stock in 2-3 weeks when the asthma and COPD data come out. 3-20X next month.
0 · Reply
raingang
raingang Aug. 19 at 2:22 PM
$CNTB 3 before Seabreeze readout. 8 after asthma readout and 12 after copd readout
1 · Reply
dcrown
dcrown Aug. 19 at 11:41 AM
$CNTB https://pubmed.ncbi.nlm.nih.gov/39998473/
0 · Reply
dcrown
dcrown Aug. 18 at 7:16 PM
$CNTB Shortly after the committee's review, James Huang executed an open-market purchase on May 29, 2026; now 13.3 mill shares , uhh
2 · Reply
TheGodsMustBeCrazy
TheGodsMustBeCrazy Aug. 17 at 12:07 PM
0 · Reply
dcrown
dcrown Aug. 17 at 11:28 AM
$CNTB ??? https://www.sec.gov/Archives/edgar/data/1835268/000119312522176648/d272618df3a.htm
3 · Reply
Teshuvahh
Teshuvahh Aug. 17 at 1:26 AM
0 · Reply
Biotech80
Biotech80 Aug. 14 at 8:01 AM
$CURI Taken 51% profit Nice week 🤑🤑🤑🤑 Into $ANNX once l feel it’s the correct entry may add more to $CNTB before aseptember data let’s see Monday 🤑
0 · Reply
mikeywo
mikeywo Aug. 13 at 8:27 PM
$CNTB can we please just say goodbye to the 2’s ? Idc if we sit in the 3’s the rest of this year but I’m tired of the 2’s.
2 · Reply
san_houston
san_houston Aug. 13 at 4:32 PM
$CNTB why the uptick?
2 · Reply
mikeywo
mikeywo Aug. 13 at 3:23 PM
0 · Reply
BennyBoy18
BennyBoy18 Aug. 13 at 3:11 PM
$CNTB sold , hopefully enter at lower position. Will off myself if they actually suceed and it blasts past $5 lol
0 · Reply